LOS ANGELES, June 2 (Xinhua) -- Eight people were injured Sunday in "a targeted terror attack" in Boulder, Colorado, authorities said. The suspect was identified as Mohamed Sabry Soliman, said Mark ...

DENVER - 专注于肿瘤学和医疗技术的TriSalus Life Sciences, Inc. (NASDAQ: TLSI)，市值约1.77亿美元，宣布任命David B. Patience为新任首席财务官，自2025年7月1日起生效。根据 InvestingPro 数据，该公司目前保持"FAIR"财务健康评分，尽管面临现金消耗挑战。Patience将接替今日因个人原因离职的James E.

SeaStar Medical的首个商业产品QUELIMMUNE (SCD-PED)于2024年获FDA批准，用于治疗危重儿科患者的严重急性肾损伤。公司的SCD疗法拥有六项治疗适应症的突破性设备认定，这可能有助于加速FDA批准流程并获得有利的报销方案。